Fund & Portfolio Comparison

Performance Comparison
Comparison Box

Portfolio Performance Comparison
Name YTD Return 1Yr AR 3Yr AR 5Yr AR 10Yr AR 15Yr AR 20Yr AR Common Inception
RGBAD (Regen BioPharma Inc.) NA 21,481.20% 1,562.01% 196.07% NA NA NA
Data as of 05/30/2023, Common starting date is 04/20/2016
More Performance Analytics Comparison
Name Start Date End Date
RGBAD (Regen BioPharma Inc.) 04/20/2016 05/30/2023
Last 1 Week 1 Yr 3 Yr 5 Yr 10 Yr 15 Yr 20 Yr Common Inception 2023 2022 2021 2020 2019 2018 2017 2016
Annualized Return (%) 36.12 21,481.20 1,562.01 196.07 NA NA NA 25,150.00 -60.00 1,328.57 16.67 -28.57 -91.60 -23.08 -27.78
Sharpe Ratio NA 28.29 3.23 0.45 NA NA NA 73,106.95 -0.47 4.85 0.05 -0.12 -0.26 -0.12 -0.15
Standard Deviation(%) NA 756.04 483.03 431.97 NA NA NA 1,177.71 129.88 273.74 327.17 254.00 350.61 195.03 252.36
Draw Down(%) NA 89.31 98.12 98.12 NA NA NA 80.08 64.31 88.49 86.84 89.33 92.76 73.47 83.97
Yield(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Data as of 05/30/2023, Common starting date is 04/20/2016
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
Ticker/Portfolio Name 3 Year 5 Year 10 Year 15 Year
RGBAD (Regen BioPharma Inc.) -73.81%
Nov 2017 – Nov 2020
-33.09%
Feb 2018 – Feb 2023
0.00%
NA
0.00%
NA
Annualized Rolling Returns Comparison (Maximum)
Ticker/Portfolio Name 3 Year 5 Year 10 Year 15 Year
RGBAD (Regen BioPharma Inc.) 1,027.50%
Apr 2020 – Apr 2023
176.06%
Mar 2018 – Mar 2023
0.00%
NA
0.00%
NA
Annualized Rolling Returns Comparison Chart

3-Year Annualized Rolling Return